참고문헌
- Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, Lichtenstein LM Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 1990:99:119-24.
- Konno S, Asano K, Okamoto K, Adachi M. Inhibition of cytokine production from humanperipheral blood leukocytes by anti-allergic agents in vitro. Eur J Pharmacol 264:265-8. https://doi.org/10.1016/0014-2999(94)00476-5
- Eliakim R, Karmeli F, Okon E, Rachmilewitz D. Ketotifen effectively prevents mucosaldamage in experimental colitis. Gut 1992:33:1498-503. https://doi.org/10.1136/gut.33.11.1498
- Karmeli F, Eliakim R, Okon E, Rachmilewitz D. Gastric mucosal damage is mediated bysubstance P and prevented by ketotifen. Gastroenterology 1991:100:1206-16.
- Eliakim R, Karmeli F, Rachmilewitz D. Ketotifen-old drug, new indication: Reduction ofgastric mucosal injury. Scand J Gastroenterol 1993:28:202-4. https://doi.org/10.3109/00365529309096072
- Sato M, Haizuka H, Asakura H. Relationship between serum IgA levels and CD4 subsets inIgA nephropathy. Nephron 1994:68:20-4. https://doi.org/10.1159/000188218
- Libetta C, Rampino T, Palumbo G, Esposito C, Dal-Canton A. Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells. J Am Soc Nephrol 1997:8:208-13.
- Taniguchi Y, Yorioka N, Oda H, Yamakido M. Platelet-derived growth factor, IL-1 beta,IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemicalstudy. Nephron 1996:74:652-60. https://doi.org/10.1159/000189470
- Parera M, Rivera F, Egido J, Campos A. The role of IL2 and serum-soluble IL-2 receptorcells in idiopathic IgA nephropathy. Clin Immunol Immunopathol 1992:63:196-9. https://doi.org/10.1016/0090-1229(92)90013-E
- Ashizawa M, Miyazaki M, Abe K, Furusu A, Isomoto H, Harada T, Ozono Y, Sakai H, Koji T, Kohno S. Detection of nuclear factor-kappa B in IgA nephropathy using Southwestern histochemistry. Am J Kidney Dis 2003:42:76-86. https://doi.org/10.1016/S0272-6386(03)00411-6
- Furusu A, Miyasaki M, Koji T, Abe Km Oaono Y, Harada T, Nakane PK, Hara K, Kohno S. Involvement of IL4 in human glomerulonephritis: an in situ hybridization study of IL4 mRNA and IL-4 receptor mRNA. J Am Soc Nephrol 1997:8:730-41.
- Montinaro V, Hevey K, A ventaggiato L, Fadden K, Esparza A, Chen A, et al. Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int 1992:42:341-53. https://doi.org/10.1038/ki.1992.295
- Chintalacharuvu SR, Emancipator SN. The glycosylation of IgA produced by murine B cellsis altered by Th2 cytokines. J Immunol 1997:159:2327-33.
- Chintalacharuvu SR, Nagy NU, Sigmund N, Nedrud JG, Amm ME, Emancipator SN. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol 2001:126:326-33. https://doi.org/10.1046/j.1365-2249.2001.01678.x
- Narendranathan M, Chitra P, KurienM, Philip J. Ketotifen in prevention of indomethacin-induced gastropathy. Indian J Gastoenterol 1999:18:76-7.
- Jones NL, Roifman CM, Griffiths AM, Sherman P. Ketotifen therapy for acute ulcerative colitis in children: a pilot study. Dig Dis Sci 1998:43:609-15. https://doi.org/10.1023/A:1018827527826
- Sakamoto-Ihara T, Suzuki Y, Kurusu A, Yamashita M, Horikoshi S, Tomino Y. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy. Inflamm Res 2007;56:421-7. https://doi.org/10.1007/s00011-007-6145-z
- Ravinal RC, Costa RS, Coimbra TM, Dantas M, dos Reis MA. Mast cells, TGF-betal and myofibroblasts expression in lupus nephritis outcome. Lupus. 2005;14:814-21. https://doi.org/10.1191/0961203305lu2188oa
- Heyman SN, Karmeli F, Brezis M, Rachmilewitz D. The effect of ketotifen on nitric oxidesynthase activity. Br J Pharmacol 1997:120:1545-51. https://doi.org/10.1038/sj.bjp.0701063
- Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protectthe renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94:1069-75. https://doi.org/10.1172/JCI117421
- Kovcs T, Kun L, Schmelczer M, Wagner L, Davin JC, Nagy J. Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. Am J Nephrol 1996:16:500-5. https://doi.org/10.1159/000169050
- Bazzi C, Sinico RA, Petrini C, Rizza V, Torpia R, Arrigo G, Ragni A, D'Amico G. Low dosesof drugs able to alter intestinal mucosal permeability to food antigens (5-aminosalicylic acid and sodium cromoglycate) do not reduce proteinuria in patientswith IgA nephropathy: a preliminary noncontrolled trial. Nephron 1992:61:192-5. https://doi.org/10.1159/000186870
- Sato M, Nakajima Y, Koshikawa S. Effect of sodium cromoglycate on an experimentalmodel of IgA nephropahty. Clin Neph 1987:27:141-6. https://doi.org/10.1159/000116211
- Jin SY, Choi IJ. The effect of sodium cromoglycate on the induction of experimental IgA nephropathy. Yonsei Med J 1990:31:33-48.
- Sato M, Takayama K, Kojima H, Koshikawa S. Sodium cromoglycate therapy in IgA nephropathy: a preliminary short-term trial. Am J Kidney Dis 1990:15:141-6.
- Yasuhiko T. IgA nephropathy: lessons from an animal model, the ddY mouse. J Nephrol 2008:21:463-7.
- Kivity S, Agami O, Topilsky M, Fireman E. Effect of nedocromil sodium and cromolinesodium on atopic basophil function. Int J Immunopharmacol 1996:18:75-8. https://doi.org/10.1016/0192-0561(95)00110-7
- Yan D, Zhou HR, Brooks KH, Pestka JJ Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin. Toxicology 1997:122:145-58. https://doi.org/10.1016/S0300-483X(97)00087-5
- Xu-Amano J, Kiyono H, Jackson RJ, Staats HF, Fujihashi K, Burrows PD, Elson CO, Pillai S, McGhee JR. Helper T cell subsets for immunoglobulin A response: oralimmunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2cells in mucosa associated tissues. J Exp Med 1993:178:1309-20. https://doi.org/10.1084/jem.178.4.1309
- H hara, M Kurita, H Morioka, T Kuwabara, K Kuroda, M Matsuhashi, N Ishii, K Miura, M Shirai. Drug induced cystitis due to ketotifen fumarate-a case report. Nippon Hinyokika GaKKai Zasshi 1992:83:1906-9.
- Cook HT, Singh SJ, Wembridge DE, Smith J, Tam FW, Pusey CD. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. Kidney Int 1999:55:1319-26. https://doi.org/10.1046/j.1523-1755.1999.00354.x